Periprosthetic Osteolysis: Induction of Vascular Endothelial Growth Factor From Human Monocyte/Macrophages by Orthopaedic Biomaterial Particles
Open Access
- 1 September 2003
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 18 (9) , 1573-1583
- https://doi.org/10.1359/jbmr.2003.18.9.1573
Abstract
VEGF and VEGF receptor, Flt-1, expression was observed in periprosthetic tissues surrounding loosened total joint implants. Exposure of monocyte/macrophages to titanium particles resulted in increased VEGF expression, p44/42 MAPK activation, and VEGF-dependent macrophage chemotaxis. Increased levels of angiogenic factors, such as VEGF, may be critically important in wear debris-induced implant loosening after total joint arthroplasty. Periprosthetic osteolysis after total hip arthroplasty occurs in association with formation of a vascularized granulomatous tissue in response to particulate debris. This study examined expression of vascular endothelial growth factor (VEGF) and the VEGF receptor in 10 periprosthetic tissues from loosened prostheses and quantified effects of titanium particles on VEGF release, intracellular signaling, and VEGF-dependent chemotaxis in primary cultures of human monocyte/macrophages. Double immunofluorescent staining showed that VEGF and Flt-1 co-localized with cells positive for the macrophage marker, CD11b, in the periprosthetic tissues. Monocyte/macrophages challenged with titanium particles showed a dose- and time-dependent release of VEGF ranging from 2.8- to 3.1-fold and exhibited increased expression of VEGF121 and VEGF165 mRNAs, reaching levels up to 5.0- and 8.6-fold, respectively, by 48 h (p < 0.01). Exposure of monocyte/macrophages to titanium particles upregulated phosphorylated-p44/42 mitogen-activated protein kinase (MAPK) within 30 minutes. Particle-induced activation of p44/42 MAPK and release of VEGF were dose-dependently suppressed by pretreatment of cells with PD98059, a specific inhibitor of p44/42 MAPK. Monocyte/macrophages challenged with titanium particles also showed a time-dependent activation of AP-1, a transcription factor associated with VEGF expression (p < 0.01). Supernatants from particle-challenged monocyte/macrophages increased macrophage chemotactic activity by 30%, which was significantly inhibited by anti-VEGF neutralizing antibody (p < 0.01). This study suggests that induction of VEGF release from monocyte/macrophages in response to orthopaedic biomaterial wear debris may contribute to periprosthetic osteolysis and implant loosening.Keywords
This publication has 43 references indexed in Scilit:
- Ligation of CD11b and CD11c β2 integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1α (MIP-1α) and MIP-1β production in primary human monocytes through a pathway dependent on nuclear factor–κBBlood, 2001
- Measurement and removal of adherent endotoxin from titanium particles and implant surfacesJournal of Orthopaedic Research, 1999
- Interleukin‐4 inhibits granulocyte‐macrophage colony‐stimulating factor, interleukin‐6, and tumor necrosis factor‐alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitroJournal of Orthopaedic Research, 1999
- Vascular Endothelial Growth Factor Can Substitute for Macrophage Colony-Stimulating Factor in the Support of Osteoclastic Bone ResorptionThe Journal of Experimental Medicine, 1999
- Expression of Gelatinase A and Its Activator MT1-MMP in the Inflammatory Periprosthetic Response to PolyethyleneJournal of Bone and Mineral Research, 1999
- Basic Fibroblast Growth Factor (bFGF) in the Synovial-like Membrane around Loose Total Hip ProsthesesScandinavian Journal of Rheumatology, 1996
- Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants.Annals of the Rheumatic Diseases, 1995
- Bone resorption activity of particulate-stimulated macrophagesJournal of Bone and Mineral Research, 1993
- The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1991
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989